Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With Eczema

NCT02691507 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DEVICE: EpiCeram Skin Barrier Emulsion
DRUG: Experimental Product 1% Colloidal Oatmeal Balm

Sponsor

Johnson & Johnson Consumer Inc. (J&JCI)